Cardiac Involvement in a Patient with Coronavirus Disease 2019 (COVID-19)

JAMA Cardiology

Volumn 5, Issue 7, 2020, Pages 819-824

  Inciardi, Riccardo M ^a   Lupi, Laura ^a   Zaccone, Gregorio ^a   Italia, Leonardo ^a   Raffo, Michela ^a   Tomasoni, Daniela ^a   Cani, Dario S ^a   Cerini, Manuel ^a   Farina, Davide ^a   Gavazzi, Emanuele ^a   Maroldi, Roberto ^a   Adamo, Marianna ^a   Ammirati, Enrico ^b   Sinagra, Gianfranco ^c   Lombardi, Carlo M ^a   Metra, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BISOPROLOL; C REACTIVE PROTEIN; CANRENOATE POTASSIUM; CHLOROQUINE; DOBUTAMINE; FUROSEMIDE; GADOLINIUM; HYDROXYCHLOROQUINE; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; POLYSTYRENESULFONATE SODIUM; STEROID; TROPONIN T;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CORONAVIRUS DISEASE 2019; COUGHING; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; HEART DISEASE; HEART EDEMA; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE NECROSIS; HUMAN; HYPOKINESIA; HYPOTENSION; MYOCARDITIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINUS BRADYCARDIA; ST SEGMENT ELEVATION; SYSTOLIC DYSFUNCTION; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VIRUS PNEUMONIA; BETACORONAVIRUS; COMPLICATION; CORONAVIRUS INFECTION; DIAGNOSTIC IMAGING; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PANDEMIC; PERICARDITIS; VIROLOGY;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; FEMALE; HUMANS; MIDDLE AGED; MYOCARDITIS; PANDEMICS; PERICARDITIS; PNEUMONIA, VIRAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 85082499194     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2020.1096     Document Type: Article

References (15)

1. World Health Organization. Pneumonia of unknown cause-China. Accessed January 5, 2020. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/
2. World Health Organization. Novel coronavirus-China. Accessed January 12, 2020. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
3. Lu R, Zhao X, Li J, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395 (10224): 565-574. doi: 10.1016/S0140-6736(20)30251-8 32007145
4. Huang C, Wang Y, Li X, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5 31986264
5. Yu CM, Wong RS, Wu EB, Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006; 82 (964): 140-144. doi: 10.1136/pgmj.2005.037515 16461478
6. Friedrich MG, Sechtem U, Schulz-Menger J,; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009; 53 (17): 1475-1487. doi: 10.1016/j.jacc.2009.02.007 19389557
7. Young BE, Ong SWX, Kalimuddin S,; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020. Published online March 3, 2020. doi: 10.1001/jama.2020.3204 32125362
8. Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020; 14 (1): 72-73. doi: 10.5582/bst.2020.01047 32074550
9. Guan WJ, Ni ZY, Hu Y,; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. Published online February 28, 2020. doi: 10.1056/NEJMoa2002032 32109013
10. Xu Z, Shi L, Wang Y, Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. Published online February 18, 2020. doi: 10.1016/S2213-2600(20)30076-X 32085846
11. Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res. 2016; 118 (3): 496-514. doi: 10.1161/CIRCRESAHA.115.306573 26846643
12. Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2008; 3: 127-155. doi: 10.1146/annurev.pathmechdis.3.121806.151534 18039131
13. Yang X, Yu Y, Xu J, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. Published online February 24, 2020. doi: 10.1016/S2213-2600(20)30079-5 32105632
14. Rahman JE, Helou EF, Gelzer-Bell R, Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004; 43 (3): 410-415. doi: 10.1016/j.jacc.2003.08.043 15013123
15. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001; 104 (9): 1076-1082. doi: 10.1161/hc3401.095198 11524405